BC
Brian Cheng JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
28%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
69.2%
Neutral
7.7%
Negative
23.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Initiated
| – | – | 1 | – |
–
| 20 Nov ‘25 14 days ago |
|
|
|
Overweight
Maintained
| $81 |
7%
downside
| 1 | +40% |
0
%
| 7 Nov ‘25 27 days ago |
|
|
|
Underweight
Downgraded
| $5 |
49%
downside
| 1 | +21% |
0
%
| 7 Nov ‘25 27 days ago |
|
|
|
Overweight
Maintained
| $18 |
0%
downside
| 1 | +26% |
0
%
| 6 Nov ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $82 |
4%
upside
| 1 | +32% |
0
%
| 6 Nov ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $23 |
13%
downside
| 1 | +45% |
0
%
| 16 Oct ‘25 1 month ago |
|
|
|
Underweight
Downgraded
| – | – | 1 | +4% |
0
%
| 10 Oct ‘25 1 month ago |
|
|
|
Underweight
Downgraded
| – | – | 1 | +16% |
0
%
| 10 Oct ‘25 1 month ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +17% |
0
%
| 2 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $33 |
44%
upside
| 1 | +26% |
0
%
| 30 Sep ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $47 |
5%
upside
| 1 | +27% |
0
%
| 26 Sep ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $20 |
6%
downside
| 1 | +39% |
0
%
| 18 Sep ‘25 2 months ago |
|
|
|
Overweight
Initiated
| $70 |
19%
upside
| 1 | -0.37% |
0
%
| 18 Sep ‘25 2 months ago |
|